Annual CFI
-$18.51 M
-$2.77 M-17.62%
31 December 2023
Summary:
ANI Pharmaceuticals annual cash flow from investing activities is currently -$18.51 million, with the most recent change of -$2.77 million (-17.62%) on 31 December 2023. During the last 3 years, it has risen by +$49.81 million (+72.91%). ANIP annual CFI is now -191.34% below its all-time high of $20.27 million, reached on 31 December 2013.ANIP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$398.52 M
-$394.07 M-8857.56%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly cash flow from investing activities is currently -$398.52 million, with the most recent change of -$394.07 million (-8857.56%) on 30 September 2024. Over the past year, it has dropped by -$393.97 million (-8652.95%). ANIP quarterly CFI is now -2161.67% below its all-time high of $19.33 million, reached on 30 June 2013.ANIP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$398.82 M
-$393.97 M-8126.42%
30 September 2024
Summary:
ANI Pharmaceuticals TTM cash flow from investing activities is currently -$398.82 million, with the most recent change of -$393.97 million (-8126.42%) on 30 September 2024. Over the past year, it has dropped by -$381.94 million (-2263.50%). ANIP TTM CFI is now -2067.81% below its all-time high of $20.27 million, reached on 31 December 2013.ANIP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.6% | -8653.0% | -2263.5% |
| 3 y3 years | +72.9% | -10000.0% | -1470.8% |
| 5 y5 years | +32.4% | -10000.0% | -1400.3% |
ANIP Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -17.6% | +82.5% | -4561.2% | at low | -8126.4% | at low |
| 5 y | 5 years | -17.6% | +82.5% | -4561.2% | at low | -8126.4% | at low |
| alltime | all time | -191.3% | +87.6% | -2161.7% | at low | -2067.8% | at low |
ANI Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$398.52 M(+8857.6%) | -$398.82 M(+8126.4%) |
| June 2024 | - | -$4.45 M(-149.8%) | -$4.85 M(-32.9%) |
| Mar 2024 | - | $8.93 M(-286.9%) | -$7.22 M(-61.0%) |
| Dec 2023 | -$18.51 M(+17.6%) | -$4.78 M(+5.0%) | -$18.51 M(+9.7%) |
| Sept 2023 | - | -$4.55 M(-33.3%) | -$16.87 M(-23.8%) |
| June 2023 | - | -$6.83 M(+190.1%) | -$22.14 M(+39.1%) |
| Mar 2023 | - | -$2.35 M(-25.1%) | -$15.91 M(+1.1%) |
| Dec 2022 | -$15.74 M(-85.1%) | -$3.14 M(-68.0%) | -$15.74 M(-83.4%) |
| Sept 2022 | - | -$9.81 M(+1524.8%) | -$94.81 M(+10.8%) |
| June 2022 | - | -$604.00 K(-72.3%) | -$85.58 M(-20.0%) |
| Mar 2022 | - | -$2.18 M(-97.4%) | -$106.92 M(+1.4%) |
| Dec 2021 | -$105.48 M(+54.4%) | -$82.21 M(>+9900.0%) | -$105.48 M(+315.5%) |
| Sept 2021 | - | -$583.00 K(-97.3%) | -$25.39 M(-17.1%) |
| June 2021 | - | -$21.95 M(+2878.3%) | -$30.61 M(+165.9%) |
| Mar 2021 | - | -$737.00 K(-65.2%) | -$11.51 M(-83.1%) |
| Dec 2020 | -$68.32 M(+148.0%) | -$2.12 M(-63.5%) | -$68.32 M(+1.1%) |
| Sept 2020 | - | -$5.81 M(+104.0%) | -$67.58 M(+6.1%) |
| June 2020 | - | -$2.85 M(-95.1%) | -$63.70 M(-1.7%) |
| Mar 2020 | - | -$57.55 M(+4088.2%) | -$64.81 M(+135.3%) |
| Dec 2019 | -$27.55 M(+0.6%) | -$1.37 M(-28.9%) | -$27.55 M(+3.6%) |
| Sept 2019 | - | -$1.93 M(-51.2%) | -$26.58 M(-38.3%) |
| June 2019 | - | -$3.96 M(-80.5%) | -$43.09 M(-5.1%) |
| Mar 2019 | - | -$20.29 M(+4884.0%) | -$45.39 M(+65.8%) |
| Dec 2018 | -$27.38 M(-74.6%) | -$407.00 K(-97.8%) | -$27.38 M(-64.5%) |
| Sept 2018 | - | -$18.44 M(+194.8%) | -$77.09 M(+26.1%) |
| June 2018 | - | -$6.25 M(+174.6%) | -$61.13 M(+6.9%) |
| Mar 2018 | - | -$2.28 M(-95.5%) | -$57.18 M(-47.1%) |
| Dec 2017 | -$107.99 M(-27.6%) | -$50.12 M(+1920.8%) | -$107.99 M(+82.2%) |
| Sept 2017 | - | -$2.48 M(+7.6%) | -$59.27 M(+2.4%) |
| June 2017 | - | -$2.30 M(-95.7%) | -$57.88 M(-50.4%) |
| Mar 2017 | - | -$53.09 M(+3722.5%) | -$116.60 M(-21.8%) |
| Dec 2016 | -$149.06 M(+356.1%) | -$1.39 M(+27.5%) | -$149.06 M(+0.2%) |
| Sept 2016 | - | -$1.09 M(-98.2%) | -$148.78 M(-14.7%) |
| June 2016 | - | -$61.03 M(-28.7%) | -$174.46 M(+53.5%) |
| Mar 2016 | - | -$85.55 M(+7642.2%) | -$113.62 M(+247.6%) |
| Dec 2015 | -$32.68 M(-8.6%) | -$1.10 M(-95.9%) | -$32.68 M(+2.4%) |
| Sept 2015 | - | -$26.77 M(>+9900.0%) | -$31.92 M(+15.3%) |
| June 2015 | - | -$198.00 K(-95.7%) | -$27.68 M(-0.2%) |
| Mar 2015 | - | -$4.61 M(+1264.5%) | -$27.73 M(-22.4%) |
| Dec 2014 | -$35.75 M(-276.4%) | -$338.00 K(-98.5%) | -$35.75 M(+7.7%) |
| Sept 2014 | - | -$22.53 M(+8804.3%) | -$33.19 M(+210.4%) |
| June 2014 | - | -$253.00 K(-98.0%) | -$10.69 M(-220.2%) |
| Mar 2014 | - | -$12.63 M(-666.3%) | $8.89 M(-56.1%) |
| Dec 2013 | $20.27 M(-3373.6%) | $2.23 M(-6661.8%) | $20.27 M(+12.9%) |
| Sept 2013 | - | -$34.00 K(-100.2%) | $17.95 M(+2.5%) |
| June 2013 | - | $19.33 M(-1634.0%) | $17.52 M(-1064.3%) |
| Mar 2013 | - | -$1.26 M(+1427.4%) | -$1.82 M(+193.5%) |
| Dec 2012 | -$619.10 K | -$82.50 K(-82.3%) | -$619.20 K(+1.3%) |
| Sept 2012 | - | -$465.40 K(+5014.3%) | -$611.00 K(+146.1%) |
| June 2012 | - | -$9100.00(-85.4%) | -$248.30 K(-55.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$62.20 K(-16.3%) | -$560.90 K(-22.1%) |
| Dec 2011 | -$719.90 K(+1091.9%) | -$74.30 K(-27.7%) | -$719.90 K(+6.0%) |
| Sept 2011 | - | -$102.70 K(-68.1%) | -$679.30 K(+17.2%) |
| June 2011 | - | -$321.70 K(+45.4%) | -$579.50 K(+111.7%) |
| Mar 2011 | - | -$221.20 K(+556.4%) | -$273.80 K(+353.3%) |
| Dec 2010 | -$60.40 K(-102.1%) | -$33.70 K(+1062.1%) | -$60.40 K(+54.9%) |
| Sept 2010 | - | -$2900.00(-81.9%) | -$39.00 K(+6.0%) |
| June 2010 | - | -$16.00 K(+105.1%) | -$36.80 K(+76.9%) |
| Mar 2010 | - | -$7800.00(-36.6%) | -$20.80 K(-100.7%) |
| Dec 2009 | $2.86 M(-74.7%) | -$12.30 K(+1657.1%) | $2.86 M(-75.0%) |
| Sept 2009 | - | -$700.00(<-9900.0%) | $11.45 M(-7.8%) |
| June 2009 | - | $0.00(-100.0%) | $12.41 M(-13.1%) |
| Mar 2009 | - | $2.87 M(-66.5%) | $14.28 M(+26.1%) |
| Dec 2008 | $11.33 M(-200.8%) | $8.58 M(+791.0%) | $11.33 M(-236.1%) |
| Sept 2008 | - | $962.80 K(-48.5%) | -$8.32 M(-10.8%) |
| June 2008 | - | $1.87 M(-2361.1%) | -$9.34 M(-17.1%) |
| Mar 2008 | - | -$82.70 K(-99.3%) | -$11.26 M(+0.2%) |
| Dec 2007 | -$11.24 M(-326.8%) | -$11.07 M(>+9900.0%) | -$11.24 M(-289.1%) |
| Sept 2007 | - | -$49.90 K(-7.2%) | $5.94 M(+1296.7%) |
| June 2007 | - | -$53.80 K(-11.8%) | $425.50 K(-86.2%) |
| Mar 2007 | - | -$61.00 K(-101.0%) | $3.09 M(-37.7%) |
| Dec 2006 | $4.96 M(-31.6%) | $6.11 M(-209.7%) | $4.96 M(+6025.7%) |
| Sept 2006 | - | -$5.57 M(-313.3%) | $80.90 K(-98.9%) |
| June 2006 | - | $2.61 M(+44.5%) | $7.29 M(-4.9%) |
| Mar 2006 | - | $1.81 M(+46.5%) | $7.67 M(+5.9%) |
| Dec 2005 | $7.24 M(-144.7%) | $1.23 M(-25.1%) | $7.24 M(+276.3%) |
| Sept 2005 | - | $1.65 M(-44.9%) | $1.92 M(-116.3%) |
| June 2005 | - | $2.98 M(+116.6%) | -$11.78 M(-20.4%) |
| Mar 2005 | - | $1.38 M(-133.7%) | -$14.79 M(-8.7%) |
| Dec 2004 | -$16.20 M(>+9900.0%) | -$4.08 M(-66.1%) | -$16.20 M(+33.6%) |
| Sept 2004 | - | -$12.06 M(>+9900.0%) | -$12.12 M(>+9900.0%) |
| June 2004 | - | -$31.90 K(+5.3%) | -$71.10 K(+81.4%) |
| Mar 2004 | - | -$30.30 K(+604.7%) | -$39.20 K(+340.4%) |
| Dec 2003 | -$8900.00(-77.2%) | -$4300.00(-6.5%) | -$8900.00(+1.1%) |
| Sept 2003 | - | -$4600.00(<-9900.0%) | -$8800.00(-33.3%) |
| June 2003 | - | $0.00(0.0%) | -$13.20 K(-41.1%) |
| Mar 2003 | - | $0.00(-100.0%) | -$22.40 K(-42.6%) |
| Dec 2002 | -$39.00 K(-55.0%) | -$4200.00(-53.3%) | -$39.00 K(-13.7%) |
| Sept 2002 | - | -$9000.00(-2.2%) | -$45.20 K(-49.8%) |
| June 2002 | - | -$9200.00(-44.6%) | -$90.00 K(-11.1%) |
| Mar 2002 | - | -$16.60 K(+59.6%) | -$101.20 K(+16.7%) |
| Dec 2001 | -$86.70 K(+100.7%) | -$10.40 K(-80.7%) | -$86.70 K(-1.5%) |
| Sept 2001 | - | -$53.80 K(+163.7%) | -$88.00 K(+129.2%) |
| June 2001 | - | -$20.40 K(+871.4%) | -$38.40 K(+12.9%) |
| Mar 2001 | - | -$2100.00(-82.1%) | -$34.00 K(-21.3%) |
| Dec 2000 | -$43.20 K(+928.6%) | -$11.70 K(+178.6%) | -$43.20 K(+37.1%) |
| Sept 2000 | - | -$4200.00(-73.8%) | -$31.50 K(+15.4%) |
| June 2000 | - | -$16.00 K(+41.6%) | -$27.30 K(+141.6%) |
| Mar 2000 | - | -$11.30 K | -$11.30 K |
| Dec 1999 | -$4200.00(-96.6%) | - | - |
| Dec 1998 | -$125.00 K | - | - |
FAQ
- What is ANI Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual CFI year-on-year change?
- What is ANI Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly CFI year-on-year change?
- What is ANI Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM CFI year-on-year change?
What is ANI Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ANIP is -$18.51 M
What is the all time high annual CFI for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual cash flow from investing activities is $20.27 M
What is ANI Pharmaceuticals annual CFI year-on-year change?
Over the past year, ANIP annual cash flow from investing activities has changed by -$2.77 M (-17.62%)
What is ANI Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ANIP is -$398.52 M
What is the all time high quarterly CFI for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly cash flow from investing activities is $19.33 M
What is ANI Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ANIP quarterly cash flow from investing activities has changed by -$393.97 M (-8652.95%)
What is ANI Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ANIP is -$398.82 M
What is the all time high TTM CFI for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM cash flow from investing activities is $20.27 M
What is ANI Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ANIP TTM cash flow from investing activities has changed by -$381.94 M (-2263.50%)